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ABSTRACT
Background: Increases in allergic diseases have been reported from various epidemiological surveys. How-
ever, a few reports demonstrate the comorbidity of food allergy (FA) and allergic march. The aim of this study
was to assess the prevalence and comorbidity of allergic diseases in Japanese students.
Methods: First-year students (n = 3,321; 2,209 male and 1,112 female) at Osaka University were asked about
allergic diseases using postal interview sheets. Personal and family histories of doctor-diagnosed allergic dis-
eases, clinical courses, and aggravating factors were included in the questionnaires.
Results: The lifetime prevalence of allergic rhinitis (AR), atopic dermatitis (AD), bronchial asthma (BA), and
FA was 35.7%, 16.5%, 9.9%, and 7.0%, respectively. Disease-specific family histories existed for AR, AD, and
BA. There was a positive correlation between the number of family histories of allergic disease and comorbidity
(R = 0.370, P < 0.001). Comorbidity with AD significantly lowered the onset age of both BA (P = 0.010) and AR
(P < 0.001). In addition, the onset age of AD was remarkably lowered by comorbidity with FA (P < 0.001).
Comorbidity with FA was the highest risk factor for the progression of allergic march. Although most students
showed improvement in AD, BA, and AR over time, the peak recurrence period was observed in adolescence.
Conclusions: These findings indicate that AD associated with FA accelerates the subsequent progression of
allergic march. Early appropriate management for genetically high-risk groups is important for the prevention of
allergic march.
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INTRODUCTION
Increases in allergic diseases, including atopic der-
matitis (AD), bronchial asthma (BA), and allergic
rhinitis (AR), over the last 30-40 years has been well
documented worldwide.1 Allergic diseases are also an
important public health problem because they signifi-
cantly increase socioeconomic burden by lowering
the quality of life and work productivity2,3 of affected
patients and their families.4
“Allergic march” refers to a subset of allergic disor-
ders that commonly begin in early childhood, such as
food allergies (FAs), AD, BA, and AR. AD and FA
have the highest incidence in the first 2 years of life.5
In infancy, sensitization to inhalant allergen is rare. In
later childhood, the prevalence of AD, FA, and food
allergen sensitization decreases; however, the preva-
lence of BA, AR, and sensitization to inhalant aller-
gens rises. Approximately one-half of early onset AD
and BA cases are outgrown by adulthood.6 However,
in an increasing number of patients, symptoms per-
sist until adulthood or occur for the first time in ado-
lescence.
Many epidemiological investigations have sug-
gested that FA is a risk factor for the appearance of
other allergic disease in later childhood.7-12 Early on-
set AD was found to be associated with high-risk IgE
levels in food sensitization.8 Although there might be
a correlation between allergic march, FA, and AD,
there is no report demonstrating allergic march from
the viewpoint of comorbidity among AD, BA, and AR
in association with FA. The aim of this study is to in-
Allergology International. 2013;62:105-112
ORIGINAL ARTICLE
1Department of Dermatology, Osaka University Graduate School
of Medicine and 2Health Care Centre, Osaka University, Osaka,
Japan.
Conflict of interest: No potential conflict of interest was disclosed.
Correspondence: Hiroyuki Murota, MD PhD, Department of Der-
matology, Osaka University Graduate School of Medicine, 2−2
Yamadaoka, Suita, Osaka 565−0871, Japan.
Email: h−murota@derma.med.osaka−u.ac.jp
Received 18 May 2012. Accepted for publication 1 September
2012.
2013 Japanese Society of Allergology
DOI: 10.2332allergolint.12-OA-0468
Kijima A et al.
106 Allergology International Vol 62, No1, 2013 www.jsaweb.jp
Table　1　General characteristics of the study subjects
Personal
history n (%
†) Male (%‡) Female (%‡)
Total 3,316 (100%) 2,209 (66.5) 1,112 (33.5)
AD 547 (16.5) 353 (64.5) 194 (35.5)
BA 329 (9.9) 252 (76.6) 77 (23.4)
AR 1,186 (35.7) 834 (70.3) 352 (29.7)
FA 233 (7.0) 155 (66.5) 78 (33.5)
None of the 
above diseases
1,739 (52.4) 1,115 (64.1) 624 (35.9)
AD, atopic dermatitis; BA, bronchial asthma; AR, allergic rhinitis; 
FA, food allergy.
†denominator of the ratio is 3,321.
‡denominator of the ratio is the total number (n) of each dis-
ease.
vestigate how allergic diseases interact with each
other and lead to allergic march by a retrospective in-
vestigation from birth to the end of adolescence.
METHODS
STUDY POPULATION AND INTERVIEW SHEET
First-year students at Osaka University were adminis-
tered postal interview sheets in 2011 (n = 3,414). The
mark sheet interview form consisted of 27 items re-
questing information about medical histories of atopic
diseases (AD, BA, AR, and FA), family histories of
atopic diseases (AD, BA, and AR), the clinical
courses of each disease (age of onset, improvement,
and recurrence), and aggravating factors, except
identifying information for the individuals. Approxi-
mately 1 month prior to the entrance ceremony, the
sheets were sent by mail to the homes of the parents
of all students who had passed the entrance exam.
We sent the interview sheets to the parents’ homes to
encourage completion of the questionnaires. The stu-
dents brought their completed sheets to a health ex-
amination after the entrance ceremony. In total, 3,365
interview sheets were returned, including 44 empty
answer sheets; therefore, 3,321 sheets were effec-
tively analyzed.
DEFINITION OF ALLERGIC DISEASE IN PER-
SONAL AND FAMILY HISTORIES
Analyses were applied to the personal and family his-
tories of allergic diseases. Personal histories of AD,
BA, AR, and FA were based on a doctor’s diagnosis at
any time during the student’s life from birth to the
present. Family histories of AD, BA, and AR of the fa-
ther, mother, siblings, and others were based on self-
reported diagnoses. The most recent event was re-
ported as the age of improvement andor recurrence.
STATISTICAL ANALYSIS
Statistical analysis was performed using the Statistical
Package for the Social Sciences (SPSS) version 19.0
for Windows. The chi-square test was used for com-
parisons between categorical variables. The age at
which each event occurred during the clinical course
(onset, improvement, and recurrence) was compared
using the unpaired Student’s t test for all dichoto-
mous variables and by analysis of variance (ANOVA)
for more than three variables. For each disease, fam-
ily histories and the relationships between events and
background factors were evaluated by odds ratios
(OR) and 95% confidence intervals (CI) with univari-
ate logistic regression analysis. For prediction of
these events, multivariate logistic regression models
were evaluated using a backward stepwise selection
method. In all analyses, a P value less than 0.05 was
considered significant.
RESULTS
LIFETIME PREVALENCE OF ALLERGIC DIS-
EASES
The mean age of the first-year students (n = 3,321)
was 18.40 ± 0.85 years (range: 18-41 years). In these
students, the lifetime prevalence of any atopic disease
from birth to the present was 47.6% (n = 1,582) and
was significantly higher in males than females
(49.52% vs. 43.88%, P = 0.002). A majority (52.4%; n =
1,739) of the students had no medical history of aller-
gic disease (Table 1).
The lifetime prevalence of each disease based on
medical diagnoses was as follows (from highest to
lowest prevalence): AR (35.7%, n = 1,185), AD (16.5%,
n = 547), BA (9.9%, n = 329), and FA (7.0%, n = 233).
Both AR (P < 0.001) and BA (P < 0.001) were signifi-
cantly more prevalent in males than in females. There
were no significant differences between genders in
terms of lifetime prevalence of AD and FA (Table 1).
The age at diagnosis for each allergic disease was
subdivided by specialty of the medical doctor per-
forming the diagnosis (Fig. 1).
ASSOCIATION OF PERSONAL AND FAMILY HIS-
TORIES
The results of multivariate logistic regression analy-
sis for the association between personal and family
histories with the risk of onset for each atopic disease
are summarized in Table 2 and Supplementary Table
1-3. AD, AR, and BA showed comorbidity with other
diseases. In AD, comorbidity with FA was the highest
risk factor (FA > BA > AR) (Table 2, Supplementary
Table 1). In BA, AD was the highest risk factor for
comorbidity (AD > FA > AR), and in AR, BA was the
highest risk factor (BA > AD > AR) (Table 2, Supple-
mentary Table 2, 3). The personal history of each dis-
ease raised the risk of prevalence of other atopic dis-
eases (Table 2, Supplementary Table 1-3).
Family history of AD was a significant risk factor
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Fig.　1　Age at diagnosis for each allergic disease subdivided by medical specialty of the 
diagnosing doctor. The ratio of allergic disease diagnosed by specifi c medical department 
in each age group. AD, atopic dermatitis; BA, bronchial asthma; AR, allergic rhinitis. In stu-
dents diagnosed with BA, 14 years of age and upward should be used only as a guide be-
cause of the few cases examined.
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for the development of AD (Table 2, Supplementary
Table 1); likewise, family history of BA was strongly
associated with the onset of BA and that of AR with
the onset of AR (Table 2, Supplementary Table 2, 3).
These findings suggest that each atopic disease
might have its own specific genetic factor. In addition,
there was a positive correlation between the number
of allergic conditions (e.g., BA, AD, and AR) in the
family history and comorbidity (Pearson’s correlation
coefficient, R=0.370, P < 0.001).
EFFECTS OF FA ON ALLERGIC MARCH
From the results presented above, atopic diseases
raise the risk of onset for other atopic diseases. We
next examined the relationship between the number
of atopic diseases, and specifically the comorbidity of
such diseases with FA. Atopic diseases were classi-
fied in seven categories, and the risk of comorbidity
with FA was analyzed for each category: “AD only,”
“BA only,” “AR only,” “AD + BA,” “AD + AR,” “BA +
AR,” and “AD + BA + AR,” using multivariate logistic
regression analysis (Table 3). In a category with only
a single disease, “AD only” was the most frequent
comorbidity with FA (“AD only” > “BA only” > “AR
only”). In a category with two diseases, the risk was
as follows: “AD + BA” > “AD + AR” > “BA + AR.” The
“AD + BA + AR” category was the most frequently ob-
served comorbidity category of all seven categories.
Thus, the prevalence rate of each disease increased
in association with the number of additional diseases
present.
AGE AT ONSET OF ALLERGIC DISEASES
The mean age of onset was compared among three
atopic diseases (AD, BA, and AR). There was a sig-
nificant difference in the mean age of onset: AD onset
was at 3.94 ± 4.79 years, BA was at 4.00 ± 3.14 years,
and AR was at 9.06 ± 4.71 years (mean ± SD, ANOVA,
P < 0.001). The ratios of the age of onset in each of
the atopic diseases are summarized in Figure 2. The
peak age of onset for AD was earlier than that for BA:
a critical peak of AD occurred in early infancy and the
peak of BA occurred in childhood. AR developed con-
stantly from early childhood to adolescence.
With regard to improvements in these allergic dis-
eases, there is a peak age during early adolescence
Kijima A et al.
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Table　2　Association of personal and family histories with the prevalence of each atopic disease analyzed by multivariate logis-
tic regression analysis
AD (n = 547) BA (n = 329) AR (n = 1,186)
%† OR (95% CI) %‡ OR (95% CI) %§ OR (95% CI)
Personal history
AD 44.4 3.59*** (2.77-4.66) 24.3 1.81*** (1.49-2.21)
BA 26.7 3.59*** (2.76-4.65) 16.4 2.24*** (1.75-2.86)
AR 52.7 1.81*** (1.48-2.21) 59.0 2.25*** (1.77-2.88)
FA 22.9 5.22*** (3.89-7.01) 23.4 2.96*** (2.13-4.13) 11.3 1.75*** (1.31-2.34)
Family history
AD
P 10.4 2.76*** (1.72-4.42) 7.3 4.1 0.61* (0.37-0.99)
M 13.8 3.85*** (2.50-5.93) 9.5 1.79*** (1.30-2.47) 7.2 1.61* (1.03-2.52)
S 39.0 3.39*** (2.64-4.32) 30.9 21.3
O 2.5 2.40 (0.99-5.87) 2.3 1.3
BA
P 6.2 12.3 4.22*** (2.54-7.04) 4.4
M 5.9 10.5 3.62*** (2.10-6.23) 5.2 1.75* (1.03-2.97)
S 14.9 23.2 2.49*** (1.70-3.67) 10.5
O 4.5 2.19* (1.09-4.38) 7.3 5.15*** (2.71-9.81) 2.9
AR
P 32.9 33.6 1.29 (0.96-1.73) 39.9 2.46*** (2.01-3.02)
M 40.2 1.28 (1.01-1.63) 43.6 1.37* (1.04-1.80) 50.1 2.77*** (2.29-3.36)
S 45.8 45.5 52.6 2.43*** (2.02-2.93)
O 2.0 3.2 2.4 5.01** (1.04-12.54)
AD, atopic dermatitis; BA, bronchial asthma; AR, allergic rhinitis; FA, food allergy; P, paternal; M, maternal; S, siblings; O, others.
*P < 0.05, **P < 0.01, ***P < 0.001.
†denominator of the ratio is 547.
‡denominator of the ratio is 329.
§denominator of the ratio is 1,186.
Table　3　Effect of food allergy (FA) for the onset of allergic march analyzed by multivariate logistic regression analysis
Personal history n (%†)
FA Disease onset risk by complication with FA
+ (%‡) - (%‡) OR (95%CI)
AD only 217 (6.5) 16.6 83.4  8.70*** (5.47-13.84)
BA only  92 (2.8)  9.8 90.2  4.49*** (2.12-9.54)
AR only  805 (24.2)  5.1 94.9  2.28*** (1.47-3.52)
AD + BA  43 (1.3) 23.3 76.7 12.55*** (5.81-27.14)
AD + AR 185 (5.6) 18.4 81.6  9.33*** (5.76-15.10)
BA + AR  91 (2.7) 14.3 85.7  6.91*** (3.56-13.39)
AD + BA + AR 103 (3.1) 14.9 85.1 32.14*** (19.59-52.74)
AD, atopic dermatitis; BA, bronchial asthma; AR, allergic rhinitis; FA, food allergy.
***P < 0.001.
†denominator of the ratio is 3,321.
for BA and a peak age for AR during late adolescence
(Fig. 2). There are no apparent peaks of improvement
for AD, but its prevalence was found in relatively
large numbers in both early childhood and during
adolescence. With regard to recurrence, all three
atopic diseases presented a peak during adolescence
(Fig. 2).
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Table　4　Risk factor link to improvement and recurrence of 
atopic dermatitis (AD)
Covariate OR (95% CI) p
Improvement 
(Yes/No)
Sex (Male/Female) 0.40 (0.24-0.65) <0.001
Onset age 0.94 (0.94-0.90) 0.006
Aggravating factor
Xerosis 0.58 (0.37-0.91) 0.019
Seasonal turning 
points
0.51 (0.32-0.82) 0.005
Sweating 0.70 (0.44-1.09) 0.116
Recurrence 
(Yes/No)
Aggravating factor
Psychological 
stress
4.80 (2.96-7.81) <0.001
Sleep 3.03 (1.38-6.67) 0.006
AD, atopic dermatitis.
Fig.　2　Clinical course of allergic disease. Clinical course (onset, improvement, and recurrence) of AD (upper), 
BA (middle), and AR (lower) were demonstrated.
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ASSOCIATION FACTORS FOR THE IMPROVE-
MENT AND RECURRENCE OF AD
Factors associated with the improvement and recur-
rence of AD symptoms were analyzed (Table 4). The
proportion of students who experienced AD improve-
ment was 72.8% in males and 81.5% in females. Early
age of onset was associated with more AD improve-
ment than late onset. Among many aggravating fac-
tors, xerosis and seasonal changes were most fre-
quently associated with more severe symptoms and
less with improvement (Table 4). Subjects with ag-
gravating factors such as psychological stress and
sleep disturbances also had significantly high recur-
rence rates.
EFFECTS OF COMORBIDITY ON ATOPIC DIS-
EASE ONSET
We next analyzed whether the age of onset for each
atopic disease was influenced by comorbidity with
other atopic diseases. Comorbidity with AD signifi-
cantly lowered the onset age of BA (P = 0.010) and
AR (P < 0.001) (Fig. 3A). In addition, the onset age of
AD was remarkably lowered by comorbidity with FA
(P < 0.001) and slightly lowered by comorbidity with
BA (P = 0.012; Fig. 3A). However, the age of onset of
BA was not influenced by comorbidity with FA (P =
0.069; Fig. 3B) or AR (P = 0.624; Fig. 3B). Con-
versely, the age of onset of AR was significantly low-
ered by comorbidity with FA (P < 0.001), BA (P <
0.001), and AD (P < 0.001; Fig. 3C).
AD that is comorbid with FA occurs earlier than
without FA (Fig. 3A), and BA comorbidity with AD
occurs earlier than without AD (Fig. 3B). Further-
more, AR comorbidity with FA, AD, or BA occurs ear-
lier than without them (Fig. 3C). These data suggest
that AD associated with FA accelerates the develop-
ment of allergic march.
DISCUSSION
Many studies demonstrate the prevalence of allergic
diseases; however, most analyzed a limited period
from infancy to later childhood andor to early ado-
lescence. In this study, we retrospectively studied the
development of allergic march from birth to late ado-
lescence.
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Fig.　3　Effects of comorbidity on the onset of atopic disease. A: Onset age was compared in BA and AR by the 
presence of comorbidity with AD. B: The age of onset of AD was compared with comorbid BA, AR, and FA. C: 
Onset age was compared in BA and AR with comorbid FA. *P < 0.05, ***P < 0.001. N.S., not signifi cant.
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In Japan, the lifetime prevalence of AD ranged be-
tween 10-16%, 4-7% for BA, and 24-29% for AR among
school children.13-16 These previous studies showed
no consensus with regard to the trend of annual
prevalence of AD in school children and adolescents:
some previous reports show an increasing prevalence
and others show a decreasing prevalence. In the pre-
sent study, lifetime prevalence of AD and BA was al-
most identical with previous studies, but that of AR
was higher.
There is disease specificity in the relationship be-
tween family history and the lifetime prevalence of al-
lergic diseases. Subjects with AD parents or siblings
had a significantly higher risk of developing AD, and
this tendency was observed for both BA and AR.
These results are similar to previously reported data
in Japan.15,17 Furthermore, the number of comorbid
diseases showed a significant positive correlation
with the number of family histories of allergic dis-
ease. These results suggest that a certain genetic
background influences the onset and comorbidity of
allergic diseases.
Subjects diagnosed with a certain allergic disease
have a greater likelihood of developing other allergic
diseases. Approximately one-third of children with se-
vere AD were reported to suffer from IgE-mediated
FA as well.18,19 In addition, FA that developed at a
young age increased the risk for AD, BA, and AR at 8
years of age7; in 9-11-year-old children, FA was highly
associated with BA and AR.20 Two prospective stud-
ies show that cow’s milk allergy is associated with
later development of either BA or AR.21,22
We showed that FA significantly raised the risk of
allergic disease comorbidity (AD, BA, and AR), espe-
cially AD, and critically increased the numbers of dis-
eases with which it was comorbid. Furthermore, FA
significantly lowered the age of onset for both AD
and AR, and subsequently, AD significantly lowered
the onset age of both BA and AR. These results sug-
gest that FA and AD are closely associated and aggra-
vate allergic march. Furthermore, Ricci et al. re-
ported that the integrated management of AD de-
creases the likelihood that affected children would
progress toward respiratory allergic disease.23 Thus,
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prompt management of AD and FA that develop in
early infancy may be a successful method for prevent-
ing allergic march.
It is not yet understood whether FA or AD is first
diagnosed and in which organ the sensitization to
food initially occurs. Two possible mechanisms were
reported as involved in the initial sensitization to food
allergens: oral to gut mucosal exposure24 and cutane-
ous exposure. Recent modern theories suggest that
the most important factor that precipitates allergic
march is an impaired epidermal barrier. There is a
clear evidence of a relationship between filaggrin
gene (FLG) mutations and AD. FLG also increased
the risk for BA with AD, and the risk for AR with
without AD.25 Moreover, the presence of an FLG mu-
tation in infants with early onset food sensitization
and AD increases the risk for BA.26,27 However, an as-
sociation of an FLG mutation with risk for FA has not
been reported. Further investigation is needed to elu-
cidate a clearer relationship between FA and allergic
march.
We showed that both improvement and recurrence
of allergic diseases are commonly outgrown during
adolescence. To prevent allergic symptoms until
adulthood, it is particularly important to elucidate re-
currence and onset factors. Based on our results,
early onset of disease or being female increased the
likelihood that allergic disease would improve. Xero-
sis, seasonal changes, and sweating were the most
important factors that made symptoms difficult to al-
leviate. An appropriate treatment including manage-
ment of these aggravating factors is important for pre-
venting AD.
There are some limitations of the present study.
First, it is doubtful whether students remembered
their allergic histories correctly because it was a ret-
rospective study. To help offset this limitation, we
sent the interview sheets to the parents so students
could ask their parents before answering. Second, FA
may be over-diagnosed in the study because FA was
defined as a doctor’s diagnosis. Few institutions or
hospitals in Japan used oral food challenge tests for
diagnoses of FA 15-20 years ago; an FA diagnosis was
usually made by a blood test. FA might instead reflect
food sensitization rather than FA diagnosed by oral
food challenge test. Finally, our study population fo-
cused on students at Osaka University. However,
these students originated from areas throughout Ja-
pan (especially western Japan) and represented an
average 18-year-old Japanese university student.
In conclusion, a dynamic change in allergic march
was demonstrated in our study. It is important to clar-
ify the clinical course of allergic diseases from in-
fancy to adulthood. Our results suggest that AD co-
morbid with FA in early childhood plays an important
role in subsequent development of allergic march.
Early childhood is thought to be a key period for the
prevention of allergic march, and adolescence is an-
other key period for the prevention of recurrence.
The prevention of recurrence would decrease allergic
disease in adulthood. Further prospective studies us-
ing large cohorts are necessary to assess this issue.
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